51 episodes

A journal club to review recent journal articles in the field of retina. The target audience are retina specialists and other healthcare professionals who want to stay up-to-date with the latest publications in the field of retina.

The Retina Channel Podcast Keyvan Koushan, MD, FRCSC

    • Health & Fitness
    • 4.3 • 10 Ratings

A journal club to review recent journal articles in the field of retina. The target audience are retina specialists and other healthcare professionals who want to stay up-to-date with the latest publications in the field of retina.

    E51-COVID-19 and anti-septics, Ocular Tissue Detection, & Ontario Surgical Backlog-Dr. Tina Felfeli

    E51-COVID-19 and anti-septics, Ocular Tissue Detection, & Ontario Surgical Backlog-Dr. Tina Felfeli

    Dr. Tina Felfeli discusses 3 articles around COVID-19 and ophthalmology: (1) Effect of various concretions and exposure times of common ophthalmology anti-septics on COVID-19 infected cell lines. (2) Effect of the pandemic on the backlog of elective ophthalmic surgical cases in the province of Ontario, Canada (3) Detection of the COVID-19 virus in different ocular tissues of a patient that tested positive for COVID-19. 
    Referenced articles:
    Felfeli T, Kasloff SB, Krishnan J, El-Defrawy SR, Mazzulli T, Cutts TA. In vitro efficacy of topical ophthalmic antiseptics against SARS-CoV-2. BMJ Open Ophthalmol. 2021 Jun 9;6(1):e000765. doi: 10.1136/bmjophth-2021-000765. PMID: 34192157; PMCID: PMC8190983. Predicting the Ophthalmic Surgical Backlog as a Result of the COVID-19 Pandemic: A population-based study and microsimulation model to inform surgical recovery plans

    Tina Felfeli, Raphael Ximenes, David MJ Naimark, Philip L Hooper, Robert J Campbell, Sherif R El-Defrawy, Beate Sander, the COVID-19 Mod Collab
    medRxiv 2021.03.25.21254375; doi:https://doi.org/10.1101/2021.03.25.21254375
    Felfeli T, Mazzulli T, Clark ST, El-Defrawy SR, Chan CC. SARS-CoV-2 Not Detectable in Ocular Specimens of a Patient with a Past Infection. Ocul Immunol Inflamm. 2021 Apr 7:1-3. doi: 10.1080/09273948.2021.1894458. Epub ahead of print. PMID: 33826479.  
     
     

    • 43 min
    E50-Vision Recovery Velocity, Momentum and Acceleration-Dr. David Almeida

    E50-Vision Recovery Velocity, Momentum and Acceleration-Dr. David Almeida

    Dr. Almeida presents a mathematical model based on Newtonian mechanics to discuss vision recovery of different anti-VEGF medications. 
    The discussed article:
    Almeida DRP, Ruzicki J, Xu K, Chin EK. Vision Recovery Velocity, Momentum and Acceleration: Advanced Vitreoretinal Analytics as Measure of Treatment Efficacy for Neovascular Age-Related Macular Degeneration. Clin Ophthalmol. 2021 Jan 18;15:189-194. doi: 10.2147/OPTH.S288621. PMID: 33500611; PMCID: PMC7822233.
     

    • 32 min
    E49-SCREENROP Study. Refining ROP Screening Guidelines- Dr. Kourosh Sabri

    E49-SCREENROP Study. Refining ROP Screening Guidelines- Dr. Kourosh Sabri

    Dr. Sabri discusses his group's analysis of various screening criteria to detect visually significant Retinopathy of Prematurity while minimizing unnecessary retinal exams.
    Discussed article:
    Sabri K, Shivananda S, Farrokhyar F, Selvitella A, Easterbrook B Kin B, Seidlitz W, Lee SK; Canadian Neonatal Network and the Canadian Association of Pediatric Ophthalmology and Strabismus. Refining evidence-based retinopathy of prematurity screening guidelines: The SCREENROP study. Paediatr Child Health. 2019 Aug 12;25(7):455-466. doi: 10.1093/pch/pxz085. PMID: 33173557; PMCID: PMC7606175.

    • 47 min
    E48-DRCR Protocol W 2-year Results: Prophylactic anti-VEGF for Mod-Severe NPDR

    E48-DRCR Protocol W 2-year Results: Prophylactic anti-VEGF for Mod-Severe NPDR

    Dr. Raj Maturi from the DRCR Retina Network discusses effect of early anti-VEGF injections in moderate-severe NPDR to prevent vision-threatening complications of diabetic retinopathy. This is the 2-year results of a 4-year study.  
    Discussed article:
    Maturi RK, Glassman AR, Josic K, Antoszyk AN, Blodi BA, Jampol LM, Marcus DM, Martin DF, Melia M, Salehi-Had H, Stockdale CR, Punjabi OS, Sun JK; DRCR Retina Network. Effect of Intravitreous Anti-Vascular Endothelial Growth Factor vs Sham Treatment for Prevention of Vision-Threatening Complications of Diabetic Retinopathy: The Protocol W Randomized Clinical Trial. JAMA Ophthalmol. 2021 Mar 30:e210606. doi: 10.1001/jamaophthalmol.2021.0606. Epub ahead of print. PMID: 33784735; PMCID: PMC8010644.

    • 32 min
    E47-Nondamaging Retinal Laser for Mac Tel Type II- Dr. Daniel Lavinsky

    E47-Nondamaging Retinal Laser for Mac Tel Type II- Dr. Daniel Lavinsky

    Dr. Daniel Lavinsky describes the results of a small randomized controlled clinical trial investigating functional and anatomical outcomes of using nondamaging retinal laser for the treatment of macular telangiectasia type II.
    The discussed article:
    Lavinsky D, Silva MOD, Chaves AE, Schneider WFM, Lavinsky F, Palanker D. FUNCTIONAL AND STRUCTURAL EFFECTS OF NONDAMAGING RETINAL LASER THERAPY FOR MACULAR TELANGIECTASIA TYPE 2: A Randomized Sham-Controlled Clinical Trial. Retina. 2021 Mar 1;41(3):487-494. doi: 10.1097/IAE.0000000000002882. PMID: 33370517.

    • 42 min
    E46- DRCR Protocol AB. Anti-VEGF vs PPV for PDR w Vit Heme-Dr. Andrew Antoszyk

    E46- DRCR Protocol AB. Anti-VEGF vs PPV for PDR w Vit Heme-Dr. Andrew Antoszyk

    Dr. Antoszyk from the DRCR Retina Network discusses Protocol AB, which compared anti-VEGF injections vs immediate pars plana vitrectomy for the treatment of vitreous hemorrhage due to proliferative diabetic retinopathy.
    The discussed article:
    Antoszyk AN, Glassman AR, Beaulieu WT, Jampol LM, Jhaveri CD, Punjabi OS, Salehi-Had H, Wells JA 3rd, Maguire MG, Stockdale CR, Martin DF, Sun JK; DRCR Retina Network. Effect of Intravitreous Aflibercept vs Vitrectomy With Panretinal Photocoagulation on Visual Acuity in Patients With Vitreous Hemorrhage From Proliferative Diabetic Retinopathy: A Randomized Clinical Trial. JAMA. 2020 Dec 15;324(23):2383-2395. doi: 10.1001/jama.2020.23027. PMID: 33320223; PMCID: PMC7739132.

    • 22 min

Customer Reviews

4.3 out of 5
10 Ratings

10 Ratings

Top Podcasts In Health & Fitness

Listeners Also Subscribed To